PROPEL Innovates the Clinical Trial Industry in 2021
At Devana Solutions, we are continuously innovating to meet the needs of the clinical trials industry. 2021 was the year of “decentralized trials,” as such, the Devana Solutions’ team developed our PROPEL technology solution to connect centralized research operations teams with decentralized clinicians, bringing the “site” to the patient’s community.
In a world in which the swiftness to find cures and treatments is as crucial as ever, the Devana team was very humbled, yet not surprised, by the adoption of this latest innovative platform by leading research organizations and especially salute the earliest adopters, including hyperCORE International, Velocity Clinical Research, Inc. and WCG PharmaSeek.
Stayed tuned as we head into 2022 since the Devana team is currently onboarding other major research organizations onto PROPEL in both the site network and IRO space but academic and health systems, as well. We are looking forward to an efficient and well-connected New Year for the clinical trials industry to keep speeding new therapies to patients!
|